NMS-P088, a CSF-1R, FLT3 and KIT inhibitor with outstanding activity on gatekeeper resistance mutations, high tolerability, and potential for combination therapiesElena Ardini, A. Lombardi Borgia,Gemma Texido,Rachele Alzani,Nilla Avanzi,Nadia Amboldi,Sabrina Cribioli, L. Mancini,Daniele Casero,Wilma Pastori,M. Montemartini,A. Montagnoli,Daniele Donati,Arturo Galvani,Antonella Isacchi,Marina CiomeiEUROPEAN JOURNAL OF CANCER（2016）引用 1|浏览74暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
